Przegaliński E, Bigajska K, Lewandowska A
Pol J Pharmacol Pharm. 1982 Nov-Dec;34(5-6):309-15.
Budipine, a new potential antiparkinsonian drug, did not affect or--in higher doses--inhibited the flexor reflex in spinal rats, having no influence on LSD- or fenfluramine-induced flexor-reflex stimulation. It did not affect the body temperature either of the rat kept at a high ambient temperature or of the rabbit in a normothermic surroundings. It weakened fenfluramine hyperthermia in heat-adapted rats, but not in rabbits. Only in high doses budipine weakened tryptamine-induced clonic convulsions of rat forepaws. Budipine partially prevented fenfluramine-induced depletion of whole brain 5-hydroxytryptamine. The above results show that budipine demonstrates some properties of 5-HT uptake inhibitors.
布地品,一种新的潜在抗帕金森病药物,对脊髓大鼠的屈肌反射无影响,或在高剂量时抑制该反射,对LSD或芬氟拉明诱导的屈肌反射刺激无影响。它对处于高环境温度下的大鼠或处于正常体温环境中的兔子的体温均无影响。它可减弱热适应大鼠的芬氟拉明热,但对兔子无效。仅在高剂量时,布地品可减弱色胺诱导的大鼠前爪阵挛性惊厥。布地品可部分预防芬氟拉明诱导的全脑5-羟色胺耗竭。上述结果表明,布地品具有5-羟色胺摄取抑制剂的某些特性。